MedTrace Logo

Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial

NCT05252884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2025-02-07

No results posted yet for this study

Summary

The objective of this study is to compare the frequency of post-thyroidectomy symptomatic and biochemical hypocalcaemia between the strategy of routine prophylactic calcium + calcitriol vs the administration of calcium guided by PTH values.

Conditions

Interventions

DIAGNOSTIC_TEST

calcium correction according to PTH levels

A PTH blood test will be performed 4 hours post-thyroidectomy. If the PTH result is \>15 pg/mL, the patient will be discharged without calcium intake; if PTH \< 15 pg/mL, start a dose of 1200 mg Calcium carbonate every 8 hours + 0.25 mcg of calcitriol every 12 hours orally for 15 days

DRUG

routine postoperative calcium and calcitriol

The patient will receive a dose of 1,200 mg Calcium carbonate every 8 hours + 0.25 mcg of calcitriol every 12 hours orally for 15 days, starting on the same day as the intervention.

Sponsors & Collaborators

  • IPS universitaria

    collaborator UNKNOWN

  • Hospital San Vicente Fundación

    collaborator OTHER

  • Clinica Las Vegas- Grupo QuironSalud

    collaborator UNKNOWN

  • Centro de Excelencia en Enfermedades de Cabeza y Cuello

    lead OTHER

Principal Investigators

  • Alvaro Sanabria, MD · Centro de Excelencia en Enfermedades de Cabeza y Cuello

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2024-10-30
Completion
2024-12-20

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05252884 on ClinicalTrials.gov